{
    "2020-05-18": [
        [
            {
                "time": "2023-10-01",
                "original_text": "一年内已连下4城：偏爱CRO和骨科的高瓴资本盯上开立医疗",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "CRO",
                        "骨科",
                        "开立医疗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-02",
                "original_text": "28只送转股走出贴权走势",
                "features": {
                    "keywords": [
                        "送转股",
                        "贴权"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-03",
                "original_text": "医药行业的投资江湖再度迎来重磅消息",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资",
                        "重磅消息"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "医药生物行业周报：武汉推全员新冠检测十天战役 医药的短中长期投资再思考",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠检测",
                        "武汉",
                        "投资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "定增进行时：薅上市公司羊毛，顶级PE机构的PK开始了",
                "features": {
                    "keywords": [
                        "定增",
                        "PE机构",
                        "上市公司"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-06",
                "original_text": "光大证券：新冠疫情后 血制品价格弹性与渗透率将提升",
                "features": {
                    "keywords": [
                        "光大证券",
                        "新冠疫情",
                        "血制品",
                        "价格弹性"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-07",
                "original_text": "【光大医药|首次覆盖】博雅生物：以血制品为主导全面发展，血浆调拨蕴含巨大弹性",
                "features": {
                    "keywords": [
                        "光大医药",
                        "博雅生物",
                        "血制品",
                        "血浆调拨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}